NanoVM 4-8 Years and Omalizumab Subcutaneous
Determining the interaction of NanoVM 4-8 Years and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: multivitamin with iron
Brand name: Fero-Folic 500, Theragran Hematinic, Ultra Enerforce
Synonyms: Multivitamin with iron, Polysaccharide-Iron Complex, Vitamin B12, and Folic Acid
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NanoVM 4-8 Years-Ombitasvir, Paritaprevir, and Ritonavir
- NanoVM 4-8 Years-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- NanoVM 4-8 Years-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- NanoVM 4-8 Years-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- NanoVM 4-8 Years-Omeclamox-Pak
- NanoVM 4-8 Years-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Naphazoline
- Omalizumab Subcutaneous-Naphazoline and Antazoline (Ophthalmic)
- Omalizumab Subcutaneous-Naphazoline and Pheniramine
- Omalizumab Subcutaneous-Naphazoline and pheniramine ophthalmic
- Omalizumab Subcutaneous-Naphazoline Hydrochloride
- Omalizumab Subcutaneous-Naphazoline nasal